This post is from a suggested group
Autonomy, Identity, and the Mind: Governing the Ethical Frontiers of the Neuromodulation Market
Description: The Neuromodulation Market, involving devices that directly alter brain function, is fraught with profound non-market ethical dilemmas concerning patient autonomy, potential identity change, and the future risk of malicious "brainjacking."
The most profound non-market ethical challenge in the Neuromodulation Market centers on autonomy and identity. Devices like Deep Brain Stimulators (DBS) can dramatically alleviate symptoms of conditions like Parkinson's or severe depression, but the alteration of brain chemistry and function can sometimes lead to perceived changes in a patient's personality, decision-making, or sense of self. This "anticipation problem" makes informed consent uniquely complex: how can a patient truly consent to a procedure that might fundamentally change who they are? Ethical practice demands a highly transparent consent process that explicitly addresses the possibility of personality shift and requires continuous psychological support to help patients navigate any perceived identity changes…
Great initiative. Would love to be part.
Adjoa Adjeley Boi-Anang.